TickerFactsScreenerDevelopers

Stoke Therapeutics, Inc. (STOK) — Operating Income

Annual figures by fiscal year, from SEC filings.

2018: -$12.78M2019: -$35.68M2020: -$53.04M2021: -$86.06M2022: -$104.36M2023: -$114.77M2024: -$101.37M2025: -$20.59M-$20.59M
2018Operating Income (USD)2025
Fiscal YearOperating IncomeChange YoY
2025-$20.59M+79.7%
2024-$101.37M+11.7%
2023-$114.77M-10.0%
2022-$104.36M-21.3%
2021-$86.06M-62.3%
2020-$53.04M-48.7%
2019-$35.68M-179.1%
2018-$12.78M—